Journal of Clinical Microbiology · 2020 · 45 citations · 8 references
Life SciencesInfectious DiseasesMicrobiologyDiagnostic MicrobiologyMedical MicrobiologyMycologyFungal DiagnosticsFungal IdentificationFungal InfectionsFungal PathogenesisFungal PathologyCase-control Study DesignClinical Biomarker AssaysFungal DetectionFungal Pathogen DetectionInvasive Aspergillosis DiagnosisInvasive Aspergillosis ManagementInvasive Fungal InfectionsLateral Flow Assays
Management of invasive aspergillosis has been improved by biomarker assays, but limited accessibility and batch testing limit the impact. Lateral flow assays (LFA) are a simple method for use outside specialist centers, provided performance is acceptable. The objective of this study was to determine the performance of the recently released IMMY sona Aspergillus LFA when testing serum samples. The study took the form of a retrospective, anonymous case/control study comprising 179 serum samples from 136 patients with invasive fungal disease, previously documented using recently revised internationally accepted definitions.
8
J. Peter Donnelly, Sharon Chen, Carol A. Kauffman et al. · Clinical Infectious Diseases · 2019 · 2.8K citations · Full text
C. Orla Morrissey, Sharon C.‐A. Chen, Tania C. Sorrell et al. · The Lancet Infectious Diseases · 2013 · 221 citations
P. Lewis White, Christopher J. Linton, M. D. Perry et al. · Clinical Infectious Diseases · 2006 · 207 citations · Full text
Medicine, Hematology, Microbiology +16
José María Aguado, Lourdes Vázquez, Mario Fernández‐Ruiz et al. · Clinical Infectious Diseases · 2014 · 156 citations · Full text